Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Apitoxin and its components against cancer, neurodegeneration and rheumatoid arthritis: limitations and possibilities
Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.ORCID iD: 0000-0002-1241-162X
Show others and affiliations
2020 (English)In: Toxins, ISSN 2072-6651, E-ISSN 2072-6651, Vol. 12, no 2, article id 66Article in journal (Refereed) Published
Abstract [en]

Natural products represent important sources for the discovery and design of novel drugs. Bee venom and its isolated components have been intensively studied with respect to their potential to counteract or ameliorate diverse human diseases. Despite extensive research and significant advances in recent years, multifactorial diseases such as cancer, rheumatoid arthritis and neurodegenerative diseases remain major healthcare issues at present. Although pure bee venom, apitoxin, is mostly described to mediate anti-inflammatory, anti-arthritic and neuroprotective effects, its primary component melittin may represent an anticancer therapeutic. In this review, we approach the possibilities and limitations of apitoxin and its components in the treatment of these multifactorial diseases. We further discuss the observed unspecific cytotoxicity of melittin that strongly restricts its therapeutic use and review interesting possibilities of a beneficial use by selectively targeting melittin to cancer cells.

Place, publisher, year, edition, pages
MDPI, 2020. Vol. 12, no 2, article id 66
Keywords [en]
apamin, apitoxin, bee venom, cancer, melittin, neurodegeneration, phospholipase A2, rheumatoid arthritis
National Category
Rheumatology and Autoimmunity Immunology in the medical area Biochemistry and Molecular Biology
Identifiers
URN: urn:nbn:se:umu:diva-215032DOI: 10.3390/toxins12020066ISI: 000519117300014PubMedID: 31973181Scopus ID: 2-s2.0-85078221145OAI: oai:DiVA.org:umu-215032DiVA, id: diva2:1802930
Available from: 2023-10-06 Created: 2023-10-06 Last updated: 2023-10-16Bibliographically approved

Open Access in DiVA

fulltext(1366 kB)10 downloads
File information
File name FULLTEXT01.pdfFile size 1366 kBChecksum SHA-512
9f45e72209abedac557de57d98a75794bc517867ada17a012d321c00b19d84de24c75a01776f5654f12e6477ce35e1e8978bbf0bd3cec2bc3210f09cbe616cf5
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Kohler, AndreasKohler, Verena

Search in DiVA

By author/editor
Kohler, AndreasKohler, VerenaDu, MingEl-Seedi, HeshamBüttner, Sabrina
In the same journal
Toxins
Rheumatology and AutoimmunityImmunology in the medical areaBiochemistry and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 10 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 132 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf